Abstract

Cerebral microdialysis (MD) may be used in patients suffering from subarachnoid hemorrhage (SAH) to detect focal cerebral ischemia. The cerebral MD catheter is usually placed in the right frontal lobe and monitors the area surrounding the catheter. This generates the concern that a fall in cerebral blood flow (CBF) and ischemic events distant to the catheter may not be detected. We aimed to investigate if there is a difference in the association between the MD parameters and CBF measured around the MD catheter compared to global cortical CBF and to CBF in the vascular territories following SAH in the early acute phase. MD catheter was placed in the right frontal lobe of 30 SAH patients, and interstitial glucose, lactate, pyruvate, glycerol, and lactate/pyruvate ratio were measured hourly. CBF measurements were performed during day 0–3 after SAH. Global cortical CBF correlated strongly with CBF around the microdialysis catheter (CBF-MD) (r = 0.911, p ≤ 0.001). This was also the case for the anterior, middle, and posterior vascular territories in the right hemisphere. A significant negative correlation was seen between lactate and CBF-MD (r = −0.468, p = 0.009). The same relationship was observed between lactate and CBF in anterior vascular territory but not in the middle and posterior vascular territories. In conclusion, global CBF 0–3 days after severe SAH correlated strongly with CBF-MD. High lactate level was associated with low global CBF and low regional CBF in the right anterior vascular territory, when the MD catheter was placed in the right frontal lobe.

Highlights

  • Today multimodal monitoring is a part of the neurointensive care (NIC) management of patients suffering severe subarachnoid hemorrhage (SAH) [1]

  • We found that bedside monitoring of cerebral blood flow (CBF) using Xenon-CT in combination with MD in patients with SAH was feasible and safe

  • Using PET, Enblad et al found that lactate, L/P ratio, and glutamate had the highest sensitivity for detecting ischemia in the area of the MD catheter [9]

Read more

Summary

Introduction

Today multimodal monitoring is a part of the neurointensive care (NIC) management of patients suffering severe subarachnoid hemorrhage (SAH) [1]. CBF & Brain Chemistry in SAH and cerebral blood flow (CBF) provides vital information on tissue at risk of developing ischemia. MD is a focal technique that measures a small region of the brain tissue, and it is recommended that, if possible, the MD catheter should be placed in the vascular territory at risk [5]. The MD catheter is routinely placed in right frontal lobe. This is based on the assumption that both the middle cerebral artery (MCA) and the anterior cerebral artery (ACA) territories will be monitored. Bedside Xenon-CT is used routinely in our NIC unit in order to assess the regional CBF in patients following SAH [6,7,8]. In a previous Xenon-CT study including 64 SAH patients, we could not find any correlation between regional CBF and aneurysm location [7]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call